Buntanetap showed dose-dependent and statistically significant improvements in cognition in the overall enrolled PD population. Parkinson’s patients with substantial cognitive decline exhibited a very ...

Low-dose niacin uptake over 12 months was associated with improvements in the UPDRS III motor score, as well as fatigue and mood in people with Parkinson disease. Niacin enhancement may lead to ...

Researchers sought to determine the relationship between neuroimaging markers and other clinical characteristics with mild parkinsonian signs in older adults. Lower gray matter integrity found at the ...

However, in patients diagnosed with PD for longer than 3 years (MH>3), with measurable declines in MDS-UPDRS Part II, 20mg buntanetap significantly improved MDS-UPDRS Part II, Part III, Part II+III, ...